The RealReal, Inc. (REAL) Dividend History

The RealReal, Inc. (REAL) is a luxury consignment platform specializing in the authenticated sale of secondhand designer apparel, accessories, jewelry, and home decor. Founded in 2011, the company operates an online marketplace and brick-and-mortar stores, emphasizing sustainable fashion by promoting the resale of high-end luxury items. The RealReal focuses on authenticity, quality, and sustainability, making luxury goods more accessible and environmentally friendly.

55 Francisco Street, San Francisco, CA, 94133
Phone: 800-215-0566
Website: https://www.therealreal.com

Dividend History

The RealReal, Inc. currently does not pay dividends

Company News

  • The luxury resale market is projected to grow from $32.47 billion in 2024 to $50.06 billion by 2030, driven by sustainability trends, tech innovations, and younger consumers' preferences for unique, affordable luxury items.

    GlobeNewswire Inc.
    Featured Companies: TDUP
  • RealReal reported strong Q2 2025 financial results, with revenue of $165 million, beating analyst expectations. The company saw growth in active buyers, improved margins, and returned to positive adjusted EBITDA, raising full-year guidance.

    The Motley Fool
  • The RealReal (REAL) delivered earnings and revenue surprises of 14.29% and 3.53%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

    Zacks Investment Research
    Featured Companies: SPB
  • The Dow Jones index closed higher by around 47 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform. FibroGen The Trade: FibroGen, Inc. (NASDAQ: FGEN) CEO Thane Wettig acquired a total of 50,000 shares an average price of $1.91. To acquire these shares, it cost around $95,470. What’s Happening: On March 11, FibroGen named Deyaa Adib, M.D. as Chief Medical Officer. What FibroGen Does: FibroGen Inc is a biotechnology company focused on ...

    Benzinga
    Featured Companies: FGEN GSAT OTLK
  • Philip Morris' Zyn pouches hit with lawsuit. Elon Musk dethroned as world's richest person after Tesla slump. RealReal is up more than 80% since earnings last week as liquidity fears fade.

    Seeking Alpha
    Featured Companies: MO PM TSLA
Page data last updated 09/07/2025 06:08:03 UTC